Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-, medium-, and low-dose Xionglong analgesic nasal spray for acute migraine (blood stasis blocking collaterals pattern)
CTR20140667Phase 2Active
- Sponsor
- Beijing Yikangtai Technology
- Start
- Oct 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Xionglong analgesic nasal spray in migraine, sponsored by Beijing Yikangtai Technology. Started Oct 2014; status: active.
02
Drugs
Xionglong analgesic nasal spray
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20140667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140667.